They are losing customers and are on a downhill. Because the stock was once higher doesn't mean it will go back there.
Dont forget afterhours trading! Good chance to get out now for $1/sh
You're right, sorry about that. The extended hours quote that i saw was actually pre-market from this morning (prior to the hold)
edit: The advisory committee recommended the drug for approval!I’ll check the pre market action tomorrow, but I’ll probably put in an order to sell at open.
sell at open at what price?ETA, just noticed my transaction from this morning never went through... so I'm not even in... any point going tomorrow at open? or wait for the next dip?
We're hoping for a pop on today's news.
Up 70%!!!
I guess that “sell at 7:32 a.m.” is the best option
Cidara Therapeutics, Inc. (CDTX)Cheap stock. Closed at .78/share Has a new drug coming out. This past Friday the FDA Staff Report came out. My doctor friend found the report enthusiastic about the drug. It is a drug for serious fungal infections. It’s given once a week. The FDA Advisory Committee is announcing their recommendation on Tuesday. They base it on the Staff Report. They’ll likely recommend it be approved. The FDA will meet in March to announce final approval or not. The stock had a 40% drop on Friday at 10:00 am. IDK why. IDK when the FDA Staff Report announcement was, but I’m guessing the drop was in response to it. The drug works against fungal infections. The company website is talking about using it for cancer patients. My Dr friend sees a large market in nursing home patients. Reduces administrative cost, even if it’s more expensive than the alternative. If these patients were sent to a hospital for treatment, the hospital can send them back much quicker than a 7 or 10 day course of medicine. CDTX Has engaged Melinta Therapeutics to market it. Maybe they'll do a good job. Either way, hospitals and nursing homes will likely use this. Long term. This is the only such drug that’s once a week. There also has not been such an anti-viral approved in a few years. The company may not pop after Tuesday’s FDA announcement even if they do recommend the drug for approval. But it’s likely to have steady sales into the future. I’m in.
Thank you so much!!
